Sign inGet started

Faerm Michael E.

Insider CIK 1647141 · VIRX Chief Financial Officer · THRX Sr VP & Chief Business Officer · ATAI Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATAI AtaiBeckley Inc. D To issuer deriv2026-09-112026-09-11285,000— $00SEC↗
ATAI AtaiBeckley Inc. D To issuer deriv2026-09-112026-09-111,275,000— $00SEC↗
ATAI AtaiBeckley Inc. D To issuer deriv2026-09-112026-09-11285,000— —0SEC↗
ATAI AtaiBeckley Inc. D To issuer deriv2026-09-112026-09-111,275,000— —0SEC↗
ATAI AtaiBeckley Inc. A Award deriv2026-03-112026-03-13285,000— $0285,000SEC↗
ATAI AtaiBeckley Inc. A Award deriv2026-03-112026-03-131,275,000— $01,275,000SEC↗
VIRX Viracta Therapeutics, Inc. A Award deriv2024-05-142024-05-16500,000— $0500,000SEC↗
INVA Innoviva, Inc. F Tax w/h2017-11-202017-11-224,470$13.17 $58.9K279,422SEC↗
INVA Innoviva, Inc. F Tax w/h2017-08-202017-08-223,179$12.28 $39.0K283,892SEC↗
INVA Innoviva, Inc. F Tax w/h2017-05-202017-05-233,176$11.86 $37.7K287,071SEC↗
INVA Innoviva, Inc. F Tax w/h2017-02-202017-02-225,860$12.04 $70.6K287,747SEC↗
INVA Innoviva, Inc. A Award2017-01-172017-01-19133,398— $0293,607SEC↗
INVA Innoviva, Inc. F Tax w/h2016-11-202016-11-222,893$10.91 $31.6K160,209SEC↗
INVA Innoviva, Inc. F Tax w/h2016-08-202016-08-239,544$11.79 $112.5K162,870SEC↗
INVA Innoviva, Inc. A Award2016-01-142016-01-1967,126— $0172,414SEC↗
THRX THERAVANCE INC A Award2015-07-232015-07-27105,288— $0105,288SEC↗